The Effect of Tocilizumab on Procalcitonin and Other Biochemical and Clinical Markers in the Setting of COVID-19 Pneumonia
Clinical trial NCT05035589 · COMPLETED
Trial details
- NCT number
- NCT05035589
- Sponsor
- Sciberras, Stephen M.D.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-20
- Primary completion
- 2021-10-20
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.